Endo chief meets healthcare reform head-on
Anticipating the effects of U.S. healthcare reform, Endo Pharmaceuticals Chief Executive David Holveck
Archive for the 'Pharma' Category
All information about Pharma, Pharma Latest News
Abbott Reports Strong Second Quarter Results
Abbott (NYSE: ABT) today announced financial results for the second quarter ended June 30, 2010.
Original Source of Abbott Reports Strong Second Quarter Results
Eisai to cut Aricept costs with move to India
What’s a drugmaker to do when its lead product falls off the patent cliff? If you’re Eisai , you move manufacturing to India. The company plans to shift production of its Alzheimer’s drug Aricept to the subcontinent in the first such move by a Japanese pharma company, Reuters reports….
Harvard unveils strict conflicts policy
Want a prestigious speaker to talk about your drugs? Forget anyone from Harvard Medical School. The
GSK settles Paxil suits for reported $1B
GlaxoSmithKline ( NYSE: GSK )
FDA panel votes to yank Avastin indication
How does it feel to watch a billion dollars in revenue circle the drain? Just ask Roche executives; their blockbuster Avastin got the thumbs-down as a breast cancer treatment at yesterday’s FDA advisory panel meeting. And if the agency follows that expert advice, the drug could lose up to…
Takeda paid Avandia panelist who voted to withdraw
Another Avandia panelist has confessed a potential conflict of interest. Dr. Abraham Thomas, who heads up the endocrinology and diabetes division at Detroit’s Henry Ford Hospital, says he was a paid speaker for Takeda Pharmaceutical–which makes Avandia’s direct rival Actos–in 2007 and 2008. And during last week’s hotly contested…
U.S. Nurses Believe They Considerably Influence Patient Health Decisions and Behavior
According to pharmaceutical and healthcare market research company Manhattan Research, U.S. nurses believe they considerably influence patients’ health decisions and behavior.
Original Source of U.S. Nurses Believe They Considerably Influence Patient Health Decisions and Behavior
Pfizer finds buyer for NY skyscraper
Pfizer ( NYSE: PFE ) has agreed to sell the New York skyscraper it’s planning to vacate as it cuts jobs and consolidates operations, sources tell Bloomberg . Report
Original Source of Pfizer finds buyer for NY skyscraper
Decentralized NHS could be a sales-rep boon
It’s a good news, bad news kind of day for pharma sales. The good news–in the U.K., some experts think that a proposed overhaul of the National Health Service could mean more jobs for sales reps and their more technical brethren, health managers. That’s because the new NHS would…